MyChesCo on MSN2d
Noramco Group Invests $25 Million to Expand Sterile Injectable Manufacturing
The Noramco Group has announced a $25 million investment to expand its Halo Pharma facility in Whippany, New Jersey, by ...
Curia Announces Expansions to Global Network of Sterile Fill-Finish Sites
ALBANY, N.Y., March 17, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading contract research, development and manufacturing organization, today announced expansion plans to its Glasgow, UK ...
The Noramco Group Invests $25 Million in Halo Pharma’s Whippany Facility to Offer Sterile Injectable Manufacturing
The expansion addresses US injectable capacity shortages and growing demand for reliable domestic sterile manufacturing.
Contract Pharma8d
Fill-Finish Contract Manufacturing: Enhancing Compliance and Flexibility with RTU Solutions
In the evolving landscape of pharmaceutical production, fill-finish contract manufacturing has become a crucial area of focus ...
Contract Pharma1d
Curia Expands Global Network of Sterile Fill-Finish Sites
Curia will expand its Glasgow, UK facility and offers updates on the ongoing expansion to its Albuquerque, NM facility.
Business Wire8d
The Noramco Group Invests $25 Million in Halo Pharma’s Whippany Facility to Offer Sterile Injectable Manufacturing
Additional syringe, cartridge, and vial options will be introduced based on demand. Meeting Industry Needs for Sterile Injectable Manufacturing Products and Services With sterile injectables ...